Skip to content

Oral Semaglutide Gets India Nod: Pill vs Injection Explained

November 13, 2026
A pile of pills and tablets

Medicine & Healthcare

By TrendScope Daily Team · November 13, 2026

Share WhatsApp Facebook X LinkedIn Copy Link

India’s drug regulator, CDSCO, has cleared Sun Pharma to manufacture and market a generic oral semaglutide tablet for type-2 diabetes — a once-daily pill version of the same molecule behind the injectable brands Ozempic and Wegovy. The approval adds a pill option to a market that, until now, has mostly been about weekly injections.

What Was Approved

Sun Pharma’s product is a once-daily oral tablet in 3 mg, 7 mg and 14 mg strengths, approved for type-2 diabetes, not weight management. It is manufactured at the company’s Kamrup, Assam facility, with the active ingredient sourced from Zhongmeihuadong Pharmaceutical in China, and is described as therapeutically equivalent to Novo Nordisk’s original oral semaglutide brand, Rybelsus. Pricing for Sun Pharma’s tablet has not been announced yet; Dr Reddy’s already sells a comparable oral generic, Obeda, at roughly ₹99, ₹135 and ₹225 per tablet for the three strengths.

Pill vs Injection: What Actually Changes

Semaglutide was originally a weekly injection because, swallowed as a plain tablet, very little of the drug survives the stomach and gets absorbed. Novo Nordisk’s workaround for the oral version is to co-formulate it with an absorption enhancer called SNAC, a small fatty-acid derivative that allows meaningful absorption once a day instead of an injection once a week.

  • Dosing: the tablet is taken once daily; the injectable form is taken once weekly.
  • How you take it: the tablet needs to be taken first thing in the morning on an empty stomach with no more than 120 ml of plain water, then a wait of at least 30 minutes before any food, drink or other medicine. The injection can be taken with or without food, at any time of day.
  • Why the ritual matters: taking the tablet with too much water, or eating before the 30-minute window is up, can reduce how much of the drug is actually absorbed.
  • Side effects: largely the same for both, since the molecule is identical — mainly digestive effects like nausea, diarrhoea and constipation, which often ease over time.

Neither form should be used by anyone with a personal or family history of medullary thyroid carcinoma or MEN 2 syndrome, and both can cause low blood sugar when combined with insulin or certain other diabetes medicines.

“Innovative coformulation with an absorption enhancer enables once-daily oral administration.”

— Novo Nordisk, NovoMedLink clinical information (on oral semaglutide’s SNAC technology)

Why This Matters for India’s Weight-Loss Drug Market

This approval is a regulatory and manufacturing story more than a pricing one — it widens who can make the tablet version in India, rather than changing how much either form costs today. We covered the broader price collapse across injectable and oral semaglutide brands in our earlier price guide, where Sun Pharma’s own tablet was already listed as pending with its price “not yet announced.” This CDSCO nod is that pending approval moving forward; the price itself is still unknown.

The choice between a daily pill and a weekly injection is a clinical one, not a cost-saving hack, and should be made with a doctor who can weigh dosing convenience, tolerance and control against each patient’s own health history.

This article is for general information and is not medical advice. Please consult a qualified doctor about your own health.

Sources: Medical Dialogues, NovoMedLink, PharmEasy


Quick questions

Is the new semaglutide tablet for weight loss or diabetes?

Sun Pharma’s newly approved tablet is cleared for type-2 diabetes, not weight management, matching how oral semaglutide is approved in India today.

Why do you need to take the semaglutide pill on an empty stomach?

Very little of the drug is absorbed if taken with food or too much water, which is why the instructions call for no more than 120 ml of water and at least a 30-minute wait before eating.

Is the oral semaglutide pill cheaper than the injection in India?

Not necessarily. Existing oral brands like Dr Reddy’s Obeda are priced per tablet (roughly ₹99-225), while injectable generics are priced per month; Sun Pharma’s new tablet’s price has not been announced.

Related on TrendScope Daily

Share WhatsApp Facebook X LinkedIn Copy Link